Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
Canada flag Canada · Delayed Price · Currency is CAD
0.620
-0.020 (-3.13%)
Mar 9, 2026, 12:25 PM EST

TSXV:EBM Cash Flow Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Oct '25 Oct '24 Oct '23 Oct '22 Oct '21 2020 - 2016
Net Income
-0.33-0.46-0.55-0.15-0.6
Upgrade
Depreciation & Amortization
0.040.110.110.110.11
Upgrade
Other Operating Activities
00.0200-0.01
Upgrade
Change in Accounts Receivable
0.03-0.030-0.010
Upgrade
Change in Accounts Payable
0.01-0.030.040.01-0.01
Upgrade
Change in Unearned Revenue
-0.01-0.060.0500.02
Upgrade
Change in Other Net Operating Assets
0.280.420.330.030.38
Upgrade
Operating Cash Flow
0.02-0.02-0.02-0-0.12
Upgrade
Capital Expenditures
----0-0.01
Upgrade
Investing Cash Flow
----0-0.01
Upgrade
Short-Term Debt Issued
-0.040.05--
Upgrade
Long-Term Debt Issued
0.02--0.060.02
Upgrade
Total Debt Issued
0.020.040.050.060.02
Upgrade
Short-Term Debt Repaid
--0.04-0.05--
Upgrade
Long-Term Debt Repaid
-0.02---0.03-
Upgrade
Total Debt Repaid
-0.02-0.04-0.05-0.03-
Upgrade
Net Debt Issued (Repaid)
-0-0-00.030.02
Upgrade
Financing Cash Flow
-0-0-00.030.02
Upgrade
Net Cash Flow
0.02-0.02-0.020.02-0.1
Upgrade
Free Cash Flow
0.02-0.02-0.02-0.01-0.12
Upgrade
Free Cash Flow Margin
2.47%-2.17%-1.95%-0.56%-12.41%
Upgrade
Free Cash Flow Per Share
-----0.00
Upgrade
Levered Free Cash Flow
0.170.180.180.020.11
Upgrade
Unlevered Free Cash Flow
0.170.180.190.020.11
Upgrade
Change in Working Capital
0.30.310.420.030.39
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.